Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents

Agilent Technologies Inc. (NYSE: A) filed a new complaint against Twist Bioscience Corp. (“Twist”) and Emily Leproust. The proposed Second Amended Complaint adds two additional defendants (Twist employee Siyuan Chen and former Twist employee Solange Glaize) and adds new facts that were recently discovered regarding the defendants’ wide-ranging theft of Agilent’s proprietary oligonucleotide synthesis technology. First, “Leproust and several other former Agilent employees who joined her at Twist . . . stole Agilent’s most sensitive documents. Using thumb drives, cloud accounts, and personal emails, Leproust, Chen, Glaize and other former Agilent employees stole hundreds of Agilent documents clearly marked ‘Confidential.’” Second, Twist’s founder Emily Leproust secretly accepted a position as CEO at Agilent competitor, Twist, yet remained an Agilent employee exposed to Agilent trade secrets and confidential information for 17 months.

Agilent’s lawsuit is pending in the Superior Court of the State of California for the County of Santa Clara, Case No. 16-cv-291137. A copy of the proposed Second Amended Complaint can be accessed here.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,500 people worldwide. Information about Agilent is available at To receive the latest Agilent news, subscribe to our Newsroom.


Agilent Technologies Inc.
Stefanie Notaney, +1-408-345-8955

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.